Costa Rica vs Mus: Hypertension effective treatment coverage (controlled) … 30-79
Costa Rica
49.7%
in 2019
Mus
34.5%
in 2019
Costa Rica rank
4th
Mus rank
1st
Hypertension effective treatment coverage (controlled) … 30-79 over time
- Costa Rica
- Mus
How they compare
Costa Rica currently reports 49.7% against 34.5% in Mus, a difference of 15.2%.
That makes Costa Rica's figure about 1.4 times Mus's.
Across all 30 years both countries report, Costa Rica has been ahead every year.
Costa Rica ranks 4th and Mus ranks 1st of 193 countries.
Costa Rica has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Costa Rica | Mus | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 11.7% | 7.8% | 3.9% | Costa Rica |
| 2000s | 21.4% | 11.9% | 9.6% | Costa Rica |
| 2010s | 41.1% | 25.2% | 16.0% | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension effective treatment coverage (controlled hypertension), Costa Rica or Mus?
- Costa Rica, at 49.7% against 34.5% in Mus as of 2019.
- What is the difference in hypertension effective treatment coverage (controlled hypertension) between Costa Rica and Mus?
- 15.2%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Mus?
- 30 years are reported by both, from 1990 to 2019.
- How do Costa Rica and Mus rank globally for hypertension effective treatment coverage (controlled hypertension)?
- Costa Rica ranks 4th and Mus ranks 1st of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension effective treatment coverage (controlled hypertension )among adults aged 30-79, age-standardized (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.